#74 Coffee: Advice for our Vice?
CLINICAL QUESTION
Does drinking coffee impact mortality or other health outcomes in the general population?
BOTTOM LINE
Coffee consumption is associated with a possible small reduction in mortality in cohort studies. While the evidence is not strong enough to recommend non-drinkers to start consuming coffee, coffee drinkers can be reassured that it does not result in harm (except in pregnancy).
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
EVIDENCE
Meta-analysis1 of 21 cohort studies including 997,464 people in US, Europe or Japan
- Largest included cohort study2 followed 402,260 people in US (age 50-71 years) for 14 years
- Drinking coffee was associated with several confounders (more likely to smoke cigarettes, drink alcohol, be physically inactive, and have poor diet)
- After adjusting for confounders, coffee drinkers (compared to those that did not drink coffee), had a statistically significant lower risk of overall mortality:
- About 15% relative risk reduction for 2-3 cups/day
- No dose-response relationship; risk was similar whether individuals drank 1 or 8 cups/day
- Cardiovascular deaths decreased, deaths due to cancer were unchanged.
- Decaffeinated coffee seems to convey similar health benefits, so the benefit may not be due to caffeine.2
- Similar evidence for drinking tea.5
- Evidence is from cohort studies, and therefore can only show association (not causation) with reduced mortality
- Unfortunately, a large randomized controlled trial is unlikely
- However, this evidence seems to rule out clinically important harm.
- Cancer rates: Some research suggests coffee consumption is associated with reduced rates of some cancers,6,7 while other studies find no association.7-10
- Coffee intake is also associated with a reduced risk of diabetes11 and depression.12
- Coffee use in pregnancy (particularly >4 cups/day) increases the risk of fetal loss.13 Pregnant women should be advised of this potential risk.
Latest Tools for Practice
#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
#377 How to slow the flow IV: Combined oral contraceptives
In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
#376 Testosterone supplementation for cis-gender men: Let’s (andro-)pause for a moment (Update)
What are the benefits and harms of testosterone supplementation in healthy cis-gender men or those with age-related low testosterone?
Coffee drinkers rejoice!